Posts

Basic Components of the Immune System

Image
  INTRODUCTION It is generally believed that the immune system evolved as the host’s defense against infectious agents, and it is well known that patients with deficiencies in the immune system generally succumb to these infectious diseases. However, as we shall see, it may well play a larger role in the elimina-tion of other foreign substances, including tumor antigens or cells and antibodies that attack self. An immune response may be conve-niently divided into two parts: (1) a specific response to a given antigen and (2) a more nonspecific augmentation to that response. An important feature of the specific response is that there is a quicker response to the antigen during a second exposure to that antigen. It is the memory of the initial response that provides the booster effect.   For convenience, the specific immune response may be divided into two parts: (1) the humoral response and (2) the cellu-lar response to a given antigen. As we shall see, however, both responses are medi-a

Antigens

  ANTIGENS Antigens are any substances that are capable, under appropriate conditions, of inducing the formation of antibodies and reacting specifically with the antibodies so produced. They react with both T-cell recognition receptors and with antibodies. These antigenic molecules may have sev-eral antigenic determinants, called  epitopes , and each epitope can bind with a specific antibody. Thus, a single antigen can bind to many different antibodies with different binding sites. Some low-molecular-weight mol-ecules called  haptens  are unable to evoke an immune response but can react with existing antibodies. These molecules need to be coupled to a carrier molecule to be antigenic. For some molecules such as drugs, the molecule needs to be conjugated to a car-rier. The carrier may be a host protein. The tertiary structure of the molecule as well as the amino acid sequence is important in determining antigenicity. Certain struc-tures such as lipids and DNA are generally poor antigens

Antibody

Image
  ANTIBODY The basic structure of the antibody molecule is depicted in Figures 1.2A and B. It consists of a four- chain structure divided into two identical heavy (H) chains with a molecular weight of 25 kDa. Each chain is composed of  domains  of 110 amino acids and is connected in a loop by a disulfide bond between two cysteine residues in the chain. The amino acid N-terminal domains of the heavy and light chains include the anti-gen-binding site. The amino acids of these variable domains vary between different antibody molecules and are thus known as the  variable  (V) regions. Most of these dif-ferences reside in the  hypervariable  areas of the molecule and are usually only six to ten amino acid residues in length. When the hypervariable regions in each chain come together along with the counterparts on the other pair of H and L chains, they form the antigen-binding site. This part of the molecule is unique to the molecule and is known as the  idiotype determinant . In any individ

T Cells and their Receptors

Image
  T CELLS AND THEIR RECEPTORS Each T cell is also committed  to a given antigen and recognizes it by one of two TCRs. They may have TCR2s composed of gamma ( γ ) and delta ( δ ) chains or TCR2s composed of another heterodimer of alpha ( α ) and beta ( β ) chains. These TCR2s are associated with a group of transmem-brance proteins on the CD3 molecule, which takes the antigen recognition sig-nal inside the cell. Signal transduction via the CD3 complex is regulated by a series of kinases, which are associated with the tails of the CD3–TCR complex and regulate phosphorylation. Deficiencies or blocks in the T-cell signaling pathways either atthe cell-surface complex or at the level of the kinases may result in various forms of immunodeficiency. Two other important antigens present on TCR2 cells recognize histocompatibility antigens and will be discussed later. The genes for TCR chains are on different chromosomes with the  β  and  α  molecules on chromosome 7, while the  α  and  δ  are on c

Major Histocompatibility Complex

Image
  MAJOR HISTOCOMPATIBILITY COMPLEX Human histocompatibility antigens are also known as human leucocyte antigens (HLA), a term that is synonymous with the MHC complex. These antigens are cell-surface glycoproteins classified as type I or type II. They can produce genetic poly-morphism with multiple alleles at each site, thus permitting a great deal of genetic variability between given individuals (see Figure 1.6  Diagrammatic representation of class I and II MHC antigens with   B 2  microglobulins and CHO carbohydrate side chains. Figure 1.6). This extensive polymorphism is important when viewed in the context of an immune system that needs to cope with an ever-increasing range of pathogens. These pathogens in turn are extremely adept at evading the immune system. Thus, the battle between invading microbe and immune recognition is constant and ever changing. Recognition of antigen by T cells is MHC restricted. Therefore, any given individual is only able to recognize antigen as part of

Adhesion Molecules

  ADHESION MOLECULES In spite of the known MHC  complex consisting of binding of a TCR to the pro-cessed antigen, which in turn is bound to the class II molecule of APCs, this is not enough for T-cell activation. One must have additional stimuli that are provided by a series of adhesion molecules on the two cell surfaces. These molecules are composed of a diverse set of cell-surface glycoproteins and play a pivotal role in mediating cell-to-cell adhesion. Adhesion molecules are divided into four major groups, (a) integrins, (b) selectins, (c) immunoglobulin superfamily, and (d) caherins. β   Integrins are heterodimers: These are divided into  α  and  β  subunits. Depending on the substructure of the  β  unit, there are five families, but for convenience  β 1  and  β 2  integrins are   involved in leucocyte–endothelial inter-actions.  β 1  integrins, also known as very late activation proteins, are so named because they appear on lymphocytes   several days after antigenic stimula-tion a

Cytokines

Image
  CYTOKINES This group of soluble molecules plays an extremely important role in clinical immunology. They are secreted by macrophages and may act as stimulatory or inhibi-tory signals between cells. Cytokines that initiate chemotaxis of leucocytes are called  chemokines .   Among the group of cytokines, there are a few of particular interest because of their stimulatory activity. Interleu-kins 1 (IL-1) and 2 (IL-2) are of particu-lar importance secondary to their role in amplifying the immune response. IL-1 acts on a wide range of cells including T and B cells. In contrast, IL-2 primarily acts on lymphocytes, although it has similar trophic effects on IL-receptor B cells and natural killer (NK) cells. (See Table 1.1 and functions.)